We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $9.16B
1-Year Est. Return 63.5%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+63.5%
3 Year Est. Return
+138.65%
5 Year Est. Return
+164.85%
10 Year Est. Return
+932.39%
AUM
$4.83B
AUM Growth
+$384M
Cap. Flow
-$36.5M
Cap. Flow %
-0.75%
Top 10 Hldgs %
21.82%
Holding
591
New
46
Increased
195
Reduced
287
Closed
20

Sector Composition

Rank Sector Weight
1 Industrials 16.04%
2 Healthcare 13.4%
3 Technology 12.04%
4 Communication Services 11.16%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CM icon
301
Canadian Imperial Bank of Commerce
CM
$109B
$1.62M 0.03%
41,447
+7,543
+22% +$282K
VCIT icon
302
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.5B
$1.6M 0.03%
19,245
-12,275
-39% -$1.02M
BIIB icon
303
Biogen
BIIB
$30.6B
$1.57M 0.03%
6,516
+935
+17% +$209K
APU
304
DELISTED
AmeriGas Partners, L.P.
APU
$1.53M 0.03%
35,539
+44
+0.1% +$1.95K
TAP icon
305
Molson Coors Class B
TAP
$7.93B
$1.52M 0.03%
30,420
+3,330
+12% +$167K
CS
306
DELISTED
Credit Suisse Group
CS
$1.5M 0.03%
+49,256
New +$1.47M
AKAM icon
307
Akamai
AKAM
$16.9B
$1.5M 0.03%
29,027
-5,850
-17% -$276K
ATI icon
308
ATI
ATI
$31.1B
$1.49M 0.03%
48,925
+32,055
+190% +$897K
CLX icon
309
Clorox
CLX
$13B
$1.47M 0.03%
17,944
-446
-2% -$37.7K
MFIN icon
310
Medallion Financial
MFIN
$249M
$1.44M 0.03%
97,021
-4,321
-4% -$63.2K
VRTX icon
311
Vertex Pharmaceuticals
VRTX
$133B
$1.44M 0.03%
19,050
+800
+4% +$63.7K
UN
312
DELISTED
Unilever NV New York Registry Shares
UN
$1.44M 0.03%
38,079
-1,633
-4% -$64.6K
ADM icon
313
Archer Daniels Midland
ADM
$38.8B
$1.41M 0.03%
38,355
+628
+2% +$22.9K
TXN icon
314
Texas Instruments
TXN
$256B
$1.41M 0.03%
34,886
+133
+0.4% +$5.17K
MKC icon
315
McCormick & Company Non-Voting
MKC
$14.3B
$1.4M 0.03%
43,284
-35,130
-45% -$1.23M
PGF icon
316
Invesco Financial Preferred ETF
PGF
$667M
$1.39M 0.03%
81,256
-45,326
-36% -$786K
NGD
317
DELISTED
New Gold Inc
NGD
$1.34M 0.03%
+224,500
New +$1.53M
ANFI
318
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$1.33M 0.03%
102,881
-14,542
-12% -$134K
CB
319
DELISTED
CHUBB CORPORATION
CB
$1.33M 0.03%
14,914
-125
-0.8% -$10.8K
RSG icon
320
Republic Services
RSG
$65.7B
$1.28M 0.03%
38,334
-11,513
-23% -$392K
IWF icon
321
iShares Russell 1000 Growth ETF
IWF
$127B
$1.27M 0.03%
65,128
-432
-0.7% -$8.27K
AVP
322
DELISTED
Avon Products, Inc.
AVP
$1.27M 0.03%
61,712
+5,301
+9% +$113K
MMP
323
DELISTED
Magellan Midstream Partners, L.P.
MMP
$1.27M 0.03%
22,470
-496
-2% -$27.3K
DGX icon
324
Quest Diagnostics
DGX
$26.2B
$1.24M 0.03%
20,058
+12,615
+169% +$755K
DO
325
DELISTED
Diamond Offshore Drilling
DO
$1.24M 0.03%
19,822
+1
+0% +$67

Similar funds

Pinnacle Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Pinnacle Associates held 591 positions worth $4.83B, up 8.6% from $4.45B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Pinnacle Associates's Q3 2013 filing shows 46 new, 195 increased, 287 reduced and 20 closed positions. Its largest new stake was Array Biopharma Inc: 2,330,780 shares worth $14.5M. The largest sale was BELO CORP SER A, an estimated $19.8M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Pinnacle Associates's largest Q3 2013 buy was Array Biopharma Inc: 2,330,780 shares worth $14.5M.
  • Pinnacle Associates added most to Vivus Inc in Q3 2013, an estimated $15.5M increase.
  • Pinnacle Associates's biggest Q3 2013 reduction was BELO CORP SER A, cutting an estimated $19.8M.
  • Pinnacle Associates fully exited ION Geophysical Corporation in Q3 2013, selling an estimated $6.28M.
  • Pinnacle Associates's ten largest holdings make up 22% of its $4.83B portfolio in Q3 2013.
  • Pinnacle Associates opened 46 new positions and closed 20 in Q3 2013.
  • Pinnacle Associates's portfolio value rose 8.6% quarter-over-quarter to $4.83B.

Based on Pinnacle Associates's 13F filing for Q3 2013, filed 14 Nov 2013.